Get started
Author

Michele Cimminiello

Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease
2016 · Nicolaus Kröger, Carlos Solano, et al. · New England Journal of Medicine · 577
PDF
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia
2015 · Enrico Tiacci, Jae H. Park, et al. · New England Journal of Medicine · 356
PDF
Imatinib for refractory chronic graft-versus-host disease with fibrotic features
2009 · Attilio Olivieri, Franco Locatelli, et al. · Blood · 233
Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial
2018 · Andrea Gallamini, Corrado Tarella, et al. · Journal of Clinical Oncology · 200
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD
2013 · Attilio Olivieri, Michele Cimminiello, et al. · Blood · 99
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial
2020 · Andrea Gallamini, Andrea Rossi, et al. · Journal of Clinical Oncology · 65
PDF
GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study
2019 · Francesca Bonifazi, Carlos Solano, et al. · The Lancet Haematology · 60
PDF
Very Low Rate of Readmission after an Early Discharge Outpatient Model for Autografting in Multiple Myeloma Patients: An Italian Multicenter Retrospective Study
2014 · Massimo Martino, Mauro Montanari, et al. · Transplantation and Cellular Therapy · 36
PDF
Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience
2021 · Massimo Martino, Annalisa Pitino, et al. · Frontiers in Oncology · 32
PDF
Melphalan versus melphalan plus busulphan in conditioning to autologous stem cell transplantation for low-risk multiple myeloma
2004 · Roberto Ria, Franca Falzetti, et al. · The Hematology Journal · 32
A Comparative Assessment of Quality of Life in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Through an Outpatient and Inpatient Model
2017 · Massimo Martino, Sabino Ciavarella, et al. · Transplantation and Cellular Therapy · 31
Adverse drug reactions after intravenous rituximab infusion are more common in hematologic malignancies than in autoimmune disorders and can be predicted by the combination of few clinical and laboratory parameters: results from a retrospective, multicenter study of 374 patients
2017 · Giovanni D’Arena, Vittorio Simeon, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 31
Early serum TARC reduction predicts prognosis in advanced‐stage Hodgkin lymphoma patients treated with a PET ‐adapted strategy
2020 · Simonetta Viviani, Arabella Mazzocchi, et al. · Hematological Oncology · 19
PDF
Graft engineering for allogeneic haploidentical stem cell transplantation
2004 · Antonio Tabilio, Franca Falzetti, et al. · Blood Cells Molecules and Diseases · 19
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real‐life experience
2021 · Fulvio Massaro, Vincenzo Pavone, et al. · Hematological Oncology · 14
PDF
The neutrophil to lymphocyte ratio (NLR) and the presence of large nodal mass are independent predictors of early response: A subanalysis of the prospective phase II PET‐2‐adapted HD0607 trial
2020 · Alessandra Romano, Chiara Pavoni, et al. · Cancer Medicine · 14
PDF
Nilotinib in steroid-refractory cGVHD: prospective parallel evaluation of response, according to NIH criteria and exploratory response criteria (GITMO criteria)
2020 · A. Olivieri, G. Mancini, et al. · Bone Marrow Transplantation · 12
Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs
2020 · Domenico Pastore, Benedetto Bruno, et al. · Annals of Hematology · 11
PDF
Prevention of Chronic GvHD after HLA-Identical Sibling Peripheral Hematopietic Stem Cell Transplantation with or without Anti-Lymphocyte Globulin (ATG). Results from a Prospective, Multicenter Randomized Phase III Trial (ATGfamilystudy)
2014 · Francesca Bonifazi, Carlos Solano, et al. · Blood · 11
Efficacy and Safety of the BRAF Inhibitor Vemurafenib in Hairy Cell Leukemia Patients Refractory to or Relapsed after Purine Analogs: A Phase-2 Italian Clinical Trial
2014 · Enrico Tiacci, Luca De Carolis, et al. · Blood · 10
Loss of bone mineral density and secondary hyperparathyroidism are complications of autologous stem cell transplantation
2007 · Roberto Ria, Anna Maria Scarponi, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 10
‘Real-life’ report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO)
2017 · L Giaccone, G Mancini, et al. · Bone Marrow Transplantation · 9
PDF
Evaluation of serological response to anti-SARS-CoV-2 mRNA vaccination in hematological patients
2022 · Sara Pasquina Pascale, Roberta Nuccorini, et al. · Frontiers in Immunology · 7
PDF
A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant
2019 · Massimo Martino, Mercedes Gori, et al. · Annals of Hematology · 7
Lenalidomide can induce graft versus leukemia effect in primary plasma cell leukemia: A case report
2009 · Attilio Olivieri, Immacolata Attolico, et al. · Leukemia Research · 7
Works count: 71
Citation count: 1,977
H-index: 14
I10-index: 21
Year
Topic
Type